Physician profile
Eduardo Ozuna
NPI 1003007469
$7,714.50
in general payments reported to CMS, 2019-2025
18 companies · $4,408 in 2025
The $4,408 reported for 2025 was more than what 92% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.28 · 2022: $378 · 2023: $909 · 2024: $1,987 · 2025: $4,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,478 · Travel and Lodging: $1,799 · Education: $26.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,478.18 |
| Travel and Lodging | $1,798.86 |
| Education | $26.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,432.20 | 2022-2024 | Senza, Vyrsa V1 |
| Spinal Simplicity, LLC | $1,817.24 | 2022-2025 | Ha Minuteman G3-R |
| Spr Therapeutics, INC | $922.88 | 2025 | Sprint Pns System |
| Globus Medical, INC. | $659.98 | 2025 | Senza, Omnia |
| Medtronic, INC. | $657.23 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Boston Scientific Corporation | $382.55 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $157.76 | 2025 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $125.34 | 2024-2025 | Evoke |
| Averitas Pharma INC. | $99.23 | 2024-2025 | Qutenza |
| Abbott Laboratories | $93.94 | 2021-2025 | Proclaim |
| Orthofundamentals, LLC | $84.00 | 2025 | Trellis Si Joint Fusion System |
| Collegium Pharmaceutical, INC. | $76.55 | 2023-2024 | Xtampza |
| Abbvie INC. | $55.83 | 2025 | |
| Si-Bone, INC. | $46.87 | 2024-2025 | |
| Arteriocyte Medical Systems, INC. | $28.66 | 2023 | Magellan |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $27.74 | 2025 | Irrisept |
| Protega Pharmaceutials INC | $23.70 | 2025 | Roxybond |
| Baxter Healthcare | $22.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Ozuna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.